References
1. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease-the
hypothesis revisited. BMJ. 1999;319(7204):245-249.
2. Ravn NH, Halling AS, Berkowitz AG, et al. How does parental history
of atopic disease predict the risk of atopic dermatitis in a child? A
systematic review and meta-analysis. J Allergy Clin Immunol.2020;145(4):1182-1193.
3. Lockett GA, Soto-Ramirez N, Ray MA, et al. Association of season of
birth with DNA methylation and allergic disease. Allergy.2016;71(9):1314-1324.
4. Litonjua AA, Gold DR. Asthma and obesity: common early-life
influences in the inception of disease. J Allergy Clin Immunol.2008;121(5):1075-1084; quiz 1085-1076.
5. Renz H, Holt PG, Inouye M, Logan AC, Prescott SL, Sly PD. An exposome
perspective: Early-life events and immune development in a changing
world. J Allergy Clin Immunol. 2017;140(1):24-40.
6. Jackson DJ, Gern JE, Lemanske RF, Jr. Lessons learned from birth
cohort studies conducted in diverse environments. J Allergy Clin
Immunol. 2017;139(2):379-386.
7. Skevaki C, Van den Berg J, Jones N, et al. Immune biomarkers in the
spectrum of childhood noncommunicable diseases. J Allergy Clin
Immunol. 2016;137(5):1302-1316.
8. Poissonnier A, Sanseau D, Le Gallo M, et al. CD95-Mediated Calcium
Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in
Lupus-Prone Mice. Immunity. 2016;45(1):209-223.
9. Tauzin S, Chaigne-Delalande B, Selva E, et al. The naturally
processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration
pathway. PLoS Biol. 2011;9(6):e1001090.
10. Daneshmandi S, Pourfathollah AA, Pourpak Z, Heidarnazhad H. Soluble
Form of Fasl (sFasL) in Adult Asthma. Iran Red Crescent Med J.2009;11(3):301-305.
11. Mezei G, Levay M, Sepler Z, Heninger E, Kozma GT, Cserhati E.
Seasonal changes of proapoptotic soluble Fas ligand level in allergic
rhinitis combined with asthma. Pediatr Allergy Immunol.2006;17(6):444-449.
12. Su KW, Chen PC, Wang IJ. Cord blood soluble Fas ligand and pediatric
atopic dermatitis. Allergy Asthma Proc. 2011;32(5):366-371.
13. Su KW, Tu YL, Chiu CY, et al. Cord Blood Soluble CD14 Predicts
Wheeze and Prolonged Cough in Young Children: The PATCH Study. Int
Arch Allergy Immunol. 2016;169(3):189-197.
14. Global Initiative for Asthma. Global Strategy for Asthma Management
and Prevention. 2017; https://ginasthma.org/ .
15. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its
Impact on Asthma (ARIA) 2008 update (in collaboration with the World
Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63
Suppl 86:8-160.
16. Hanifin JM. Atopic dermatitis. J Allergy Clin Immunol.1984;73(2):211-226.
17. Sunyer J, Anto JM, Castellsague J, Soriano JB, Roca J. Total serum
IgE is associated with asthma independently of specific IgE levels. The
Spanish Group of the European Study of Asthma. Eur Respir J.1996;9(9):1880-1884.
18. American Thoracic S, European Respiratory S. ATS/ERS recommendations
for standardized procedures for the online and offline measurement of
exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.Am J Respir Crit Care Med. 2005;171(8):912-930.
19. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of
spirometry. Eur Respir J. 2005;26(2):319-338.
20. İkincioğullari A, Doğu F, Bozdoğan G, et al. Serum sFas and
sFas-Ligand Levels in Childhood Asthma. Pediatric Asthma, Allergy
& Immunology. 2004;17(2):126-130.
21. Abe R. Toxic epidermal necrolysis and Stevens-Johnson syndrome:
soluble Fas ligand involvement in the pathomechanisms of these diseases.J Dermatol Sci. 2008;52(3):151-159.
22. LA OR, Tai L, Lee L, et al. Membrane-bound Fas ligand only is
essential for Fas-induced apoptosis. Nature.2009;461(7264):659-663.
23. Cullen SP, Henry CM, Kearney CJ, et al. Fas/CD95-induced chemokines
can serve as ”find-me” signals for apoptotic cells. Mol Cell.2013;49(6):1034-1048.
24. Lau S, Illi S, Sommerfeld C, et al. Early exposure to house-dust
mite and cat allergens and development of childhood asthma: a cohort
study. Multicentre Allergy Study Group. Lancet.2000;356(9239):1392-1397.
25. Cox DW, Mullane D, Zhang GC, et al. Longitudinal assessment of
airway responsiveness from 1 month to 18 years in the PIAF birth cohort.Eur Respir J. 2015;46(6):1654-1661.
Table 1. Cord blood soluble FasL level and allergic outcomes at 7 years
old